Related references
Note: Only part of the references are listed.Petri Net Siphon Analysis and Graph Theoretic Measures for Identifying Combination Therapies in Cancer
Behnam Behinaein et al.
IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (2018)
Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations
Adam A. Friedman et al.
CLINICAL CANCER RESEARCH (2017)
Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis
Julia E. Maxson et al.
CANCER RESEARCH (2016)
The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
E. Chang et al.
LEUKEMIA (2016)
BH3 profiling identifies heterogeneous dependency on Bcl-2 family members in multiple myeloma and predicts sensitivity to BH3 mimetics
C. Touzeau et al.
LEUKEMIA (2016)
The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism
Mary Ann Anderson et al.
BLOOD (2016)
Update on rational targeted therapy in AML
Danielle Shafer et al.
BLOOD REVIEWS (2016)
Finally, An Apoptosis-Targeting Therapeutic for Cancer
Carlo M. Croce et al.
CANCER RESEARCH (2016)
Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
Avery Polk et al.
CLINICAL CANCER RESEARCH (2016)
Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutations
Lavinia Spain et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent
Jessica T. Leonard et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia
Jessica T. Leonard et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells
Bing Z. Carter et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia
Kami Maddocks et al.
SEMINARS IN ONCOLOGY (2016)
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
Marina Konopleva et al.
CANCER DISCOVERY (2016)
Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression
Giovanni Galletti et al.
CELL REPORTS (2016)
Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States
Bruno C. Medeiros et al.
ANNALS OF HEMATOLOGY (2015)
Therapeutically Targetable ALK Mutations in Leukemia
Julia E. Maxson et al.
CANCER RESEARCH (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Database of Genomic Biomarkers for Cancer Drugs and Clinical Targetability in Solid Tumors
Rodrigo Dienstmann et al.
CANCER DISCOVERY (2015)
Precision medicine for cancer with next-generation functional diagnostics
Adam A. Friedman et al.
NATURE REVIEWS CANCER (2015)
Analysis of drug combinations: current methodological landscape
Julie Foucquier et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Identification of small molecules that support human leukemia stem cell activity ex vivo
Caroline Pabst et al.
NATURE METHODS (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
Rongqing Pan et al.
CANCER DISCOVERY (2014)
Genomic impact of transient low-dose decitabine treatment on primary AML cells
Jeffery M. Klco et al.
BLOOD (2013)
Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study
Neil P. Shah et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
BH3 profiling - Measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions
Victoria Del Gaizo Moore et al.
CANCER LETTERS (2013)
Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening
Jeffrey W. Tyner et al.
CANCER RESEARCH (2013)
Emergence of Polyclonal FLT3 Tyrosine Kinase Domain Mutations during Sequential Therapy with Sorafenib and Sunitinib in FLT3-ITD-Positive Acute Myeloid Leukemia
Sharyn D. Baker et al.
CLINICAL CANCER RESEARCH (2013)
Circulating Tumor Cells: Liquid Biopsy of Cancer
Catherine Alix-Panabieres et al.
CLINICAL CHEMISTRY (2013)
Overcoming stroma-mediated treatment resistance in chronic lymphocytic leukemia through BCL-2 inhibition
Matthew S. Davids et al.
LEUKEMIA & LYMPHOMA (2013)
Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML
Julia E. Maxson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Genomic Landscapes and Clonality of De Novo AML
John Brewin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
Tea Pemovska et al.
CANCER DISCOVERY (2013)
Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways
Jing Tang et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation
Cheuk Him Man et al.
BLOOD (2012)
Survival for older patients with acute myeloid leukemia: a population-based study
Betul Oran et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Dynamic Single-Cell Network Profiles in Acute Myelogenous Leukemia Are Associated with Patient Response to Standard Induction Therapy
Steven M. Kornblau et al.
CLINICAL CANCER RESEARCH (2010)
Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
Farhad Ravandi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
RNAi screen for rapid therapeutic target identification in leukemia patients
Jeffrey W. Tyner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia
Tim C. P. Somervaille et al.
CANCER CELL (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Single cell profiling of potentiated phospho-protein networks in cancer cells
JM Irish et al.
CELL (2004)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Y Yamamoto et al.
BLOOD (2001)
Share Paper
